Pfizer is voluntarily recalling approximately 65,370 units of Hospira brand injectable medications, including Epinephrine Injection and 8.4% Sodium Bicarbonate Injection. The recall includes 49,620 vials of Epinephrine (1mg/10mL) and 15,750 vials of 8.4% Sodium Bicarbonate (50mEq/50 mL) distributed to clinical settings. These products are being recalled due to a lack of assurance of sterility, which means the medications might not be completely free of germs or bacteria. To date, no injuries or adverse health events have been reported related to this recall.
Using an injectable medication that is not sterile can lead to serious, life-threatening infections, including sepsis or localized abscesses at the injection site. This is particularly dangerous for patients already in critical care or with weakened immune systems.
Distributed by Hospira, Inc.
Distributed by Hospira, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.